Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 13.09 M14.86 M15.21 M17.99 M 61.16 M Research & development ———— — Operating income 14.45 M10.77 M11.76 M29.08 M 66.06 M Non-Operating Income, Total -753 K-2.02 M-968 K14.8 M 11.05 M Interest expense, net of interest capitalized 2.35 M2.1 M2.07 M1.98 M 8.5 M Non-Operating Income, excl. Interest Expenses -1.86 M-2.06 M-1.94 M13.98 M 8.12 M Unusual income/expense -1.24 M-2.06 M-1.1 M-1.16 M -5.56 M Pretax income 11 M6.98 M8.79 M26.45 M 53.22 M Equity in earnings ———— — Taxes 913 K3.35 M3.07 M17.93 M 25.26 M Non-controlling/minority interest ———— — After tax other income/expense 1.18 M-988 K-1.36 M-396 K -1.57 M Net income before discontinued operations 10.09 M3.64 M5.72 M8.52 M 27.96 M Discontinued operations ———— — Net income 10.09 M3.64 M5.72 M8.52 M 27.96 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 10.07 M3.63 M5.71 M8.51 M 27.94 M Basic earnings per share (Basic EPS) 0.410.150.230.35 1.14 Diluted earnings per share (Diluted EPS) 0.40.150.230.35 1.13 Average basic shares outstanding 24.6 M24.61 M24.47 M24.5 M — Diluted shares outstanding 24.91 M24.82 M24.65 M24.77 M — EBITDA 23.17 M20.34 M22.03 M19.2 M 84.75 M EBIT 14.06 M11.09 M11.74 M9.16 M 46.05 M Cost of revenue 336.77 M313.41 M325.11 M338.62 M 1.31 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 9.12 M9.25 M10.29 M10.04 M 38.7 M